FDA Drug Application (021423) for NEURONTIN by PARKE DAVIS

Back to FDA Applications sponsored by PARKE DAVIS

Application Number021423
Product Number001
FormCAPSULE; ORAL
Dosage800MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameNEURONTIN
Active IngredientGABAPENTIN

Active IngredientCount
List of drugs with Active Ingredient GABAPENTIN3


Back to FDA Applications sponsored by PARKE DAVIS